Related Experiment Video
Updated: May 10, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Immunological abnormalities associated with hereditary haemorrhagic telangiectasia
A Guilhem1, C Malcus, B Clarivet
1CHU de Montpellier, Service de Médecine Interne A, Hôpital Saint Eloi, Montpellier, France.
Patients with Hereditary Haemorrhagic Telangiectasia (HHT) show immune system changes, including low T cell and NK cell counts, and higher IgG and IgA levels. Further research is needed on low IgM levels and infection risk.
Area of Science:
- Immunology
- Genetics
- Vascular Biology
Background:
- Hereditary Haemorrhagic Telangiectasia (HHT) is a genetic disorder linked to TGF-β superfamily coreceptor mutations.
- HHT patients present with vascular malformations and an unexplained susceptibility to severe bacterial infections.
Purpose of the Study:
- To evaluate the immunological functions in HHT patients.
- To assess immune system parameters using standard tests for primary immunodeficiencies.
Main Methods:
- A prospective study of 42 adult HHT patients.
- Assessed lymphocyte subpopulations, proliferation, immunoglobulin levels, and neutrophil/monocyte functions.
Main Results:
- No alterations in innate immunity were observed.
- Adaptive immunity showed lymphopenia (decreased CD4+, CD8+, NK cells) and increased IgG, IgA levels.
- Lymphopenia primarily affected naive T cells; lymphocyte proliferation was normal.
Conclusions:
- HHT patients exhibit immune abnormalities: T cell (CD4, CD8) and NK cell lymphopenia, with elevated IgG and IgA.
- Low immunoglobulin M levels warrant further investigation as a potential infection risk factor in HHT.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Regulation of Angiogenesis and Blood Supply
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Esophageal Varices-I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy

